Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of a safety and efficacy analysis

被引：0

作者：

Arkenau, HT

Schmoll, H

Kubicka, S

Kretzschmar, A

Freier, W

Seufferlein, T

Graeven, U

Grothey, A

Hinke, A

Porschen, R

机构：

[1] Clin Bremen E, Clin Internal Med, Bremen, Germany

[2] Univ Halle Wittenberg, Halle Saale, Germany

[3] Hannover Med Sch, D-3000 Hannover, Germany

[4] Charite, Berlin, Germany

[5] Private Oncol Clin, Hildesheim, Germany

[6] Univ Ulm, Med Clin, Ulm, Germany

[7] Hosp Maria Hilf, Monchengladbach, Germany

[8] Mayo Clin, Rochester, MN USA

[9] Res Inst WISP Langenfeld, Res Inst WISP, Langenfeld, Germany

[10] Clin Bremen E 10, Bremen, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：283 / 283

页数：1